Soleno Therapeutics, Inc. (SLNO) Tops Q3 EPS by 42c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of $0.47, $0.42 better than the analyst estimate of $0.05. Revenue for the quarter came in at $66 million versus the consensus estimate of $47.46 million.

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Allison Transmission to Join S&P MidCap 400; Goodyear Tire & Rubber to Join S&P SmallCap 600
• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Constellation Brands (STZ) Tops Q1 EPS by 18c